Cardiovascular Endocrinology & Metabolism is a leading open-access journal dedicated to advancing our understanding of the interconnections between cardiovascular health and endocrine functions. Published by Lippincott Williams & Wilkins, this journal serves as a vital resource for researchers and clinicians alike, providing timely insights into the intricate relationships between metabolic disorders and cardiovascular diseases. With an impressive impact factor and categorized in Q2 for both Cardiology and Cardiovascular Medicine as well as Endocrinology, Diabetes, and Metabolism, it holds a significant position within its respective fields. The journal has been fully open access since its inception in 2012, ensuring that critical research is accessible to a global audience. By fostering innovation and collaboration, Cardiovascular Endocrinology & Metabolism aims to promote better health outcomes and stimulate novel research directions, making it an essential resource for professionals striving to bridge the gaps between these two critical domains.

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

The Journal of Obesity & Metabolic Syndrome, published by the Korean Society for the Study of Obesity, is a premier, open access journal that has been championing research in the realms of endocrinology, diabetes, and metabolism since its inception in 2012. With an ISSN of 2508-6235 and an E-ISSN of 2508-7576, this journal has quickly established itself as a leading publication, currently ranked in the Q1 category within its field and occupying the 46th position out of 244 in Scopus' Medicine category, with an impressive 81st percentile ranking. The journal serves as a vital platform for disseminating high-quality research and innovative findings related to obesity and metabolic disorders, fostering collaboration among researchers, healthcare professionals, and students dedicated to advancing knowledge and treatment strategies. For those interested in contributing or gaining access to cutting-edge research, the journal emphasizes its commitment to open access principles by providing unrestricted access to its content, thereby enhancing the visibility and impact of studies within the global scientific community.

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

NEUROENDOCRINOLOGY is a prestigious interdisciplinary journal published by KARGER, serving the vibrant fields of cellular and molecular neuroscience, endocrine systems, and metabolism. With an ISSN of 0028-3835 and an E-ISSN of 1423-0194, this journal stands at the forefront of neuroendocrinology research, boasting an impactful position in the academic community, as highlighted by its 2023 Scopus rankings placing it in the top quartiles across multiple relevant categories. Since its inception in 1965, NEUROENDOCRINOLOGY has consistently contributed to the advancement of knowledge and understanding in the interplay between the nervous system and endocrine functions. Although it does not currently offer Open Access, the journal aims to disseminate groundbreaking studies, reviews, and clinical insights that address critical issues in neuroendocrine interactions. With its headquarters in Basel, Switzerland, NEUROENDOCRINOLOGY remains a vital resource for researchers, professionals, and students eager to explore the complexities of neuroendocrine dynamics and their implications for health and disease.

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

Molecular Metabolism is a premier, open-access journal published by Elsevier, dedicated to advancing the understanding of metabolic processes at the molecular level. With an ISSN of 2212-8778 and a proud presence in Germany, the journal has made significant contributions to the fields of Cell Biology and Molecular Biology, consistently achieving a Q1 ranking in both categories as of 2023. The journal’s scope encompasses cutting-edge research that explores metabolic pathways, their regulation, and implications for human health, underscoring the interplay between metabolism and various biological functions. Researchers and professionals benefit from the journal’s robust visibility, as it ranks #40 among 410 journals in Molecular Biology and #35 among 285 in Cell Biology according to Scopus metrics, placing it in the top 10 percentile in its field. With open access since 2012, Molecular Metabolism ensures that groundbreaking research is available to all, fostering a collaborative and inclusive academic environment. Its commitment to excellence and accessibility makes it an invaluable resource for those invested in metabolic research.

The International Journal of Endocrinology and Metabolism is a leading peer-reviewed publication dedicated to advancing knowledge and research in the fields of endocrinology, diabetes, and metabolism. Published by BRIEFLAND in the Netherlands, this journal features original research, comprehensive reviews, and insightful clinical studies that explore the multifaceted aspects of hormonal disorders and metabolic conditions. With an impact factor that places it in the Q3 quartile category for 2023, the journal serves as a critical resource for academics and practitioners aiming to stay at the forefront of this dynamic field. Spanning from 2010 to 2024, the journal offers an enriching platform for innovative ideas and practices, fostering collaboration among scholars and healthcare professionals alike. Although not open access, the content is meticulously curated to ensure high-quality scientific discourse, positioning the International Journal of Endocrinology and Metabolism as an essential reference for those dedicated to improving health outcomes related to endocrine and metabolic disorders.